| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662059 | International Journal of Cardiology | 2018 | 33 Pages |
Abstract
Restarting OAC therapy after a major bleeding event in AF was associated with a positive clinical benefit when compared to non-restarting OAC, with a significant reduction in any thromboembolism and all-cause mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marco Proietti, Giulio Francesco Romiti, Imma Romanazzi, Alessio Farcomeni, Laila Staerk, Peter Brønnum Nielsen, Gregory Y.H. Lip,